C.Q. Pharmaceutical Holding Co., Ltd.

SZSE:000950 Stock Report

Market Cap: CN¥9.0b

C.Q. Pharmaceutical Holding Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Wei Liu

Chief executive officer

CN¥978.1k

Total compensation

CEO salary percentagen/a
CEO tenure3.2yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Analysis Article • Feb 24

C.Q. Pharmaceutical Holding (SZSE:000950) Is Reinvesting At Lower Rates Of Return

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analysis Article • Dec 03

Is C.Q. Pharmaceutical Holding (SZSE:000950) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Nov 12

C.Q. Pharmaceutical Holding's (SZSE:000950) Returns On Capital Not Reflecting Well On The Business

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Oct 25

C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 34x, you may consider C.Q...
Analysis Article • Jul 13

Is C.Q. Pharmaceutical Holding (SZSE:000950) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Jun 11

C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

C.Q. Pharmaceutical Holding Co., Ltd.'s ( SZSE:000950 ) price-to-earnings (or "P/E") ratio of 15.9x might make it look...
Analysis Article • Mar 28

Does C.Q. Pharmaceutical Holding (SZSE:000950) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

CEO

Wei Liu (51 yo)

3.2yrs
Tenure
CN¥978,100
Compensation

Mr. Wei Liu is General Manager of C.Q. Pharmaceutical Holding Co., Ltd. since April 25, 2023.He is Director of C.Q. Pharmaceutical Holding Co., Ltd. from May 18, 2023. He is President of Chongqing Pharmac...

Leadership Team

NamePositionTenureCompensationOwnership
Wei Liu
GM & Director3.2yrsCN¥978.10kno data
Tian Qiu
Financial Director4.3yrsCN¥727.90kno data
Shaohong Li
Executive Deputy GM & Director8.8yrsCN¥795.80kno data
Yihai Chen
Deputy GM & Non-Independent Director3.3yrsCN¥817.20kno data
Qinghua Yang
Deputy General Manager3.3yrsCN¥817.20kno data
Yi Yin
Accounting Supervisorno datano datano data
3.3yrs
Average Tenure
54yo
Average Age

Experienced Management: 000950's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Wei Liu
GM & Director3.1yrsCN¥978.10kno data
Shaohong Li
Executive Deputy GM & Director7.5yrsCN¥795.80kno data
Yihai Chen
Deputy GM & Non-Independent Director2.6yrsCN¥817.20kno data
Quan Yuan
Chairman8.8yrsno datano data
Yun Wei
Director3.3yrsno datano data
Fei Cheng
Director2.1yrsno datano data
Zhen Zeng
Non Independent Director4.6yrsno datano data
Xueying Lu
Employee Representative Supervisor5.9yrsno datano data
Fengwen Chen
Independent Director2.6yrsCN¥100.00kno data
Shengqiang Liu
Independent Director2.6yrsCN¥100.00kno data
Hong Liu
Independent Director2.6yrsCN¥100.00kno data
Zhongxi Cai
Independent Director2.6yrsCN¥100.00kno data
2.8yrs
Average Tenure
52yo
Average Age

Experienced Board: 000950's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/17 08:33
End of Day Share Price 2026/06/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

C.Q. Pharmaceutical Holding Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tielin ChenTopsperity Securities
Xinming ZhouTopsperity Securities